Edema Clinical Trials in Houston, Texas
9 recruitingHouston, Texas
Showing 1–9 of 9 trials
Recruiting
Phase 3
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema (DME)Diabetic Macular EdemaDME
EyePoint Pharmaceuticals, Inc.240 enrolled39 locationsNCT07449936
Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
Diabetic Macular Edema
Hoffmann-La Roche634 enrolled92 locationsNCT04108156
Recruiting
Phase 2
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
Lymphedema
M.D. Anderson Cancer Center50 enrolled1 locationNCT06989099
Recruiting
Phase 2
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
LymphedemaFibrosis
M.D. Anderson Cancer Center295 enrolled1 locationNCT06494111
Recruiting
Phase 2
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
LymphedemaFibrosisHead &Amp; Neck Cancer+1 more
M.D. Anderson Cancer Center250 enrolled1 locationNCT06912763
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Macular Edema Secondary to Inflammation
Kodiak Sciences Inc150 enrolled33 locationsNCT06996080
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Macular Edema Secondary to Inflammation
Kodiak Sciences Inc150 enrolled33 locationsNCT06990399
Recruiting
Not Applicable
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
LymphedemaEdema
Fibralign Corporation60 enrolled2 locationsNCT04606030